XORTX Therapeutics (NASDAQ:XRTX) Shares Pass Above 200-Day Moving Average – Time to Sell?

XORTX Therapeutics Inc. (NASDAQ:XRTXGet Free Report) passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $2.56 and traded as high as $2.72. XORTX Therapeutics shares last traded at $2.37, with a volume of 33,670 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of XORTX Therapeutics in a research report on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Get Our Latest Stock Analysis on XORTX Therapeutics

XORTX Therapeutics Stock Performance

The stock has a market capitalization of $3.67 million, a price-to-earnings ratio of -0.90 and a beta of 0.80. The company has a 50 day moving average of $2.33 and a 200 day moving average of $2.56.

XORTX Therapeutics (NASDAQ:XRTXGet Free Report) last issued its earnings results on Friday, May 15th. The technology company reported ($0.58) earnings per share (EPS) for the quarter.

Institutional Trading of XORTX Therapeutics

An institutional investor recently raised its position in XORTX Therapeutics stock. Citadel Advisors LLC lifted its holdings in shares of XORTX Therapeutics Inc. (NASDAQ:XRTXFree Report) by 124.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 86,326 shares of the technology company’s stock after purchasing an additional 47,858 shares during the quarter. Citadel Advisors LLC owned about 1.24% of XORTX Therapeutics worth $70,000 as of its most recent filing with the Securities and Exchange Commission. 0.23% of the stock is currently owned by institutional investors.

XORTX Therapeutics Company Profile

(Get Free Report)

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.

Featured Articles

Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.